Additionally, STK4 and STK38 are critical serine/threonine kinases regulating the cell cycle and apoptosis [30]; they also exhibited an upregulation trend in the PTX+3-MA group, suggesting that 3-MA may induce tumor cell cycle arrest and apoptosis, thereby enhancing drug efficacy. The gene discussed is STK4; the disease is neoplasm.